PASI Improvement in the First 12 weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE Guselkumab Clinical Trials. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 6, p. s237, 2023. DOI: 10.25251/skin.7.supp.237. Disponível em: https://skin.dermsquared.com/skin/article/view/2457. Acesso em: 14 apr. 2025.